Jung Kim

23PUBLICATIONS
153CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Developmental genetics (incl. sex determination)Epidemiological methodsHaematological tumoursGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Apr 10, 2026
Genomic ascertainment of PALB2-related cancer predisposition: PALB2-related cancer predisposition.

Douglas R Stewart, Jung Kim, Jeremy S Haley

|Apr 23, 2025
Prognostic Significance of Germline DICER1 Pathogenic or Likely Pathogenic Variants in Outcomes of Ovarian Sertoli-Leydig Cell Tumor.

Alexander T Nelson, Dave Watson, Kenneth S Chen

|Feb 24, 2025
Germline Pathogenic DROSHA Variants Are Linked to Pineoblastoma and Wilms Tumor Predisposition.

Peter N Fiorica, Lisa Golmard, Jung Kim

|Jan 13, 2025
Genomic ascertainment to quantify prevalence and cancer risk in adults with pathogenic and likely pathogenic germline variants in RASopathy genes.

Jung Kim, Gina Ney, Megan N Frone

|Nov 05, 2024
Genome-first determination of the prevalence and penetrance of eight germline myeloid malignancy predisposition genes: a study of two population-based cohorts.

Rachel M Hendricks, Jung Kim, Jeremy S Haley

|Sep 17, 2024
Cancer in Multilineage Mosaic RASopathies due to Pathogenic Variants in HRAS or KRAS: A Systematic Review and Meta-analysis.

Jonas Windrich, Gina M Ney, Philip S Rosenberg

Pageof 4

Frequent Collaborators

15 joint publications

Douglas R Stewart

5 joint publications

Jeremy S Haley

4 joint publications

Sharon A Savage

4 joint publications

Kris Ann P Schultz